Fidelity is a privately owned investment management firm that caters to a diverse clientele, including individual investors, businesses, financial advisors, and institutions. The company offers a broad range of financial services, such as retirement planning, estate planning, wealth management, and life insurance. Additionally, Fidelity specializes in discount brokerage and provides various investment products including mutual funds, annuities, and managed portfolios. The firm emphasizes the financial well-being of its clients by conducting in-house research to inform its investment strategies. With a focus on helping clients achieve their financial goals, Fidelity plays a significant role in the financial services industry.
Element Labs develops AI processors for inference.
Home First Finance
Post in 2025
Home First Finance Company is an affordable housing finance company focused on providing housing loans to first-time buyers of affordable homes, specifically those priced between Rs. 5 lakhs and Rs. 30 lakhs. The company aims to serve customers who face challenges in obtaining loans from traditional banks and housing finance companies. In addition to housing loans, Home First Finance also offers loans for purchasing commercial properties, loans against property, and construction finance. Recognizing the complexities of the home buying process, the company assists consumers by addressing their concerns related to financing, eligibility, documentation, and ownership, guiding them through their journey towards homeownership.
Nuro
Series E in 2025
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the development of self-driving vehicles specifically designed for local goods transportation. Incorporated in 2016, Nuro aims to transform local commerce through its fleet of fully autonomous, electric vehicles that facilitate the delivery of a wide range of products, including food and pharmaceuticals. By enabling retailers to efficiently and safely deliver goods to customers, Nuro enhances the convenience of local commerce and meets the growing demand for autonomous delivery solutions.
Plaid
Venture Round in 2025
Plaid Inc. is a technology platform that facilitates the connection between consumers' bank accounts and various financial applications. Founded in 2012 and headquartered in San Francisco, the company aims to democratize financial services by providing developers with tools and infrastructure to create innovative financial products. Plaid's offerings include a suite of APIs that allow access to detailed transaction histories, real-time account balances, and user identity verification, among other functionalities. These tools enable financial institutions and developers, ranging from startups to large corporations, to build secure and user-friendly applications for personal finance, consumer payments, lending, and more. By streamlining the integration with traditional banking systems, Plaid enhances the ability of consumers and businesses to manage their financial activities efficiently.
Runway
Series D in 2025
Runway is an applied AI research company focused on revolutionizing the fields of art, entertainment, and human creativity. It offers an AI-powered video editing platform designed for professionals, providing innovative tools that utilize original image and video creation methods. By inventing intuitive interfaces for synthetic manipulation and editing, Runway enables users to edit videos and generate new content through text prompts. This approach simplifies the creative process for artists, designers, and filmmakers, allowing them to harness advanced technology in a user-friendly manner.
Retym
Series D in 2025
Retym is a semiconductor startup focused on developing innovative technologies for the data center and telecommunications sectors. The company's expertise lies in semiconductor technology, specifically designed to enhance optical communications and support deep learning and artificial intelligence applications. With a team comprising ASIC designers and optical communications specialists, Retym aims to identify and create disruptive solutions that advance optical networking and digital signal processing technology. By doing so, Retym seeks to enable businesses to construct next-generation data centers, thereby transforming industry standards and capabilities.
HeartFlow
Convertible Note in 2025
HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.
Capital Markets Gateway
Series C in 2025
Capital Markets Gateway Inc. is a financial technology firm based in Chicago, Illinois, with additional locations in New York and Seattle. Founded in 2015, the company focuses on modernizing equity capital markets by providing a platform that delivers real-time information and analytics to investors, underwriters, and issuers. This platform enables users to monitor capital raising activities, conduct due diligence, and make informed investment decisions while facilitating collaboration among participants. Since its launch in 2017, Capital Markets Gateway has garnered the trust of over 100 buy-side firms, managing a combined $20 trillion in assets under management, along with support from 10 investment banks. The platform emphasizes transparency and workflow efficiencies, serving as a digital system of record for firm-wide deal activity.
Celestial AI
Series C in 2025
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing cutting-edge computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design, combined with innovative features, facilitates easy content creation. Moreover, Celestial AI emphasizes intelligent data integration and prioritizes security, ensuring that users achieve impressive and reliable results.
Anthropic
Series E in 2025
Anthropic is an artificial intelligence research company dedicated to enhancing the safety and reliability of AI systems. The firm focuses on developing large-scale AI models that are interpretable, steerable, and aligned with human values. Its research encompasses various areas, including natural language processing, human feedback, scaling laws, reinforcement learning, and code generation. The company aims to produce AI systems that prioritize transparency and safety, enabling clients to better understand both the opportunities and risks associated with artificial intelligence. Anthropic's initial product, Claude, serves as an AI assistant designed for a range of tasks, reflecting the company's commitment to creating trustworthy AI solutions.
Amaero International
Post in 2025
Amaero International Ltd is an Australian company that specializes in the manufacturing of large format complex metal components through laser-based additive manufacturing processes. Founded in 2013 and headquartered in Notting Hill, the company utilizes advanced technologies such as gas atomization and hot isostatic pressing to produce high-temperature powder metals and specialty alloys, including refractory and titanium powders. Amaero serves a diverse range of sectors, including aviation, defense, aerospace, energy, and medical, while also catering to the tool and die industries. Its offerings encompass research and development, contract manufacturing, design and prototyping, and the sale of 3D printing equipment and consumables. Additionally, Amaero has established a strategic partnership with the University of Adelaide to advance additive manufacturing in South Australia.
Saluda Medical
Venture Round in 2025
Saluda Medical is a commercial-stage medical device company focused on developing innovative treatments for chronic neurological conditions, particularly chronic neuropathic pain. The company utilizes a unique closed-loop neuromodulation platform that senses and measures neural responses to stimulation. This technology automatically adjusts the therapy based on real-time neurophysiological feedback, allowing for personalized treatment tailored to each patient's specific needs. By monitoring the patient's neural fingerprint, Saluda Medical’s devices enable the precise delivery of electrical stimulation, ultimately improving the management of chronic back pain and enhancing patient outcomes.
Tenstorrent
Series D in 2024
Tenstorrent Inc. is a technology company based in Toronto, Canada, with an additional office in Austin, Texas, founded in 2016. The company specializes in the development and manufacturing of application-specific integrated circuits (ASICs) tailored for machine learning and data processing tasks. Its hardware architecture is designed to support a range of applications, from battery-powered Internet of Things (IoT) devices to large-scale cloud servers, providing scalable solutions for deep learning. Tenstorrent's offerings enable developers and researchers in the artificial intelligence sector to enhance computational performance and adapt algorithms effectively, positioning the company as a key player in advancing AI technology.
Boosted.ai
Venture Round in 2024
Boosted.ai is an artificial intelligence company focused on improving portfolio management for the financial industry through distributed machine learning. Its flagship platform, Boosted Insights, enables portfolio managers to utilize advanced quantitative investing techniques without the need for coding or a data science background. The company develops machine learning software that enhances the investment decision-making process by conducting deep analyses of market data. By automating and simplifying complex tasks, Boosted.ai makes sophisticated investment tools accessible to all investment professionals, empowering them to achieve higher returns.
Oura
Series D in 2024
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
CoreWeave
Secondary Market in 2024
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
BETA Technologies
Series C in 2024
BETA Technologies is an electric aerospace company focused on developing electric aircraft and advanced flight control systems aimed at promoting clean aviation technology. The company designs a self-sufficient ecosystem of electric vertical takeoff and landing (eVTOL) aircraft that meets the transportation needs of people and goods while adhering to environmental principles. BETA's technology encompasses all-electric aircraft and a comprehensive charging infrastructure to support various electric vehicles, enhancing the efficiency and sustainability of transportation. The company also offers training programs for pilots and maintenance personnel, serving clients in cargo, passenger, and emergency response sectors, thereby enabling more efficient, cleaner, and faster transportation solutions.
Crusoe Energy Systems
Series D in 2024
Crusoe Energy Systems Inc., based in Denver, Colorado, develops innovative technology and solutions aimed at addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which allows upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing. This service not only helps oil and gas producers reduce routine flaring of natural gas but also assists them in achieving regulatory compliance and maintaining production levels amid increasing regulations and pipeline constraints. Crusoe Energy Systems is committed to creating solutions that benefit the environment, local communities, and energy producers alike.
Lightmatter
Series D in 2024
Lightmatter is a technology company that specializes in designing photonic chips that facilitate data processing and communication through light. By leveraging integrated optical technology, Lightmatter develops efficient processors capable of significantly accelerating artificial intelligence-driven computations. Its innovative chips enhance critical operations in neural networks through programmable photonic elements that are fabricated alongside conventional transistors. This approach allows clients to achieve high-quality evaluations while maintaining low power consumption, particularly for software algorithms used in image recognition and natural language processing. Lightmatter serves various sectors, including artificial intelligence, cloud computing, and telecommunications, with the goal of advancing computing tasks through light-based technology.
Wolfspeed
Post in 2024
Wolfspeed is a leading manufacturer specializing in wide bandgap semiconductors, particularly silicon carbide (SiC) and gallium nitride (GaN) materials and devices. The company plays a crucial role in the transformation of the semiconductor industry, supporting the transition to electric vehicles, the deployment of faster 5G networks, and advancements in renewable energy and energy storage systems. Wolfspeed offers a range of products designed for power and radio-frequency applications, including use in transportation, power supplies, inverters, and wireless systems. With a workforce of over 550 skilled employees, the company boasts a robust intellectual property portfolio of approximately 2,000 patents and patent applications. Its operations are primarily based in Europe, with additional revenue derived from the United States, China, Hong Kong, and other regions.
City Therapeutics
Series A in 2024
City Therapeutics is a biopharmaceutical company focusing on engineering next-generation small-interfering RNAs (siRNAs) to enhance RNAi-based therapies. The company develops a pipeline of innovative RNAi therapeutics aimed at addressing various disease indications. City Therapeutics prioritizes improving and expanding RNAi technology to achieve better patient outcomes. The leadership team includes experienced scientists and industry professionals dedicated to advancing the field of RNA interference.
Triveni Bio
Series B in 2024
Triveni Bio is a biotech company advancing novel antibody treatments for I&I disorders. Using a genetics-driven precision medicine approach, the company aims to demonstrate proof-of-concept early in drug development by harnessing deep insights into genetic and mechanistic biology. The company's drug discovery platform aims to create targeted therapies for immunological and inflammatory diseases.
OpenAI
Venture Round in 2024
OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.
PNB Housing Finance
Post in 2024
PNBHFL provides housing loans to individuals and corporate bodies for construction, purchase, repair and up-gradation of houses. It also provides loans for commercial space, loan against property and loan for purchase of residential plots.
Anduril Industries
Series F in 2024
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Applied Intuition
Secondary Market in 2024
Applied Intuition, Inc. is a company that creates software infrastructure to facilitate the safe development, testing, and deployment of autonomous vehicles at scale. Founded in 2017 and headquartered in Sunnyvale, California, the company also maintains offices in Silicon Valley and Detroit, Michigan. Its advanced simulation infrastructure software offers a comprehensive suite of products focused on simulation and analytics, enabling automotive industries to thoroughly test and expedite the development of their autonomous vehicle technologies. By providing sophisticated tools designed for scalability, Applied Intuition supports the automotive sector in navigating the complexities of autonomous vehicle deployment effectively.
Waymo
Series C in 2024
Waymo is a self-driving technology company focused on enhancing mobility by creating safe and efficient transportation solutions. Established from advancements in Google's research since 2009, Waymo aims to improve the movement of people and goods through its innovative software and sensor technology. In 2015, the company marked a significant milestone by conducting the world's first fully autonomous trip on public roads in a vehicle devoid of traditional driving controls. Waymo continually refines its technology through extensive simulation testing, accumulating over one billion miles of virtual testing annually, while its autonomous vehicles have logged more than two million miles on public roads in four U.S. cities. By employing integrated sensors and artificial intelligence, Waymo's technology is designed to detect various obstacles such as pedestrians, cyclists, and road conditions, ensuring a safe and convenient on-demand travel experience for users.
Frore Systems
Series C in 2024
Frore Systems is a technology company based in San Jose, California, specializing in thermal management solutions for consumer devices. The company develops advanced cooling chips, specifically the AirJet® Mini and AirJet® Pro, which utilize piezoelectric MEMS technology to provide efficient and silent heat dissipation. These active cooling solutions significantly enhance device performance by outperforming traditional fan-based systems. With additional offices in Taiwan and South Korea, Frore Systems is positioned to impact the computing industry by enabling manufacturers to improve the thermal efficiency and performance of their devices.
CoreWeave
Series C in 2024
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
PSP Projects
Post in 2024
PSP Projects Ltd is a multidisciplinary construction company based in India, specializing in a wide range of construction and allied services. The company focuses on various sectors, including industrial, institutional, government, government residential, and residential projects. PSP Projects operates within a single segment of construction project activities, offering comprehensive services that cover the entire construction value chain. These services range from initial planning and design to actual construction and post-construction activities, catering to both private and public sector enterprises. The company's operations are primarily concentrated in India, where it generates its revenue.
Vodafone Idea
Post in 2024
Vodafone Idea is a prominent Indian telecommunications operator that offers comprehensive voice and data services across the country. Established through the merger of Vodafone India and Idea Cellular, the company primarily focuses on mobility services, which account for the majority of its revenue. It operates a vast telecommunications infrastructure, including fiber networks and mobile towers, to support its service offerings. Vodafone Idea primarily generates its revenue from the Indian market, positioning itself as a key player in the country's telecommunications sector. The company's operations encompass various aspects of information technology and telecommunications, catering to a diverse customer base.
SiMa.ai
Series C in 2024
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
MMI
Series C in 2024
We believe that all patients deserve the most innovative, open surgical treatment options so they can live their fullest lives. We’re on a mission to advance robotic technology that pushes the limits of soft tissue open surgery and opens new opportunities for surgeons to restore quality of life for more patients with complex conditions. The Symani® Surgical System is a first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery to restore quality of life for more patients.
Axis Bank
Post in 2023
Axis Bank, established in 1994 and headquartered in Mumbai, India, is the third largest private sector bank in the country. The bank offers a wide range of financial products and services, including personal loans, car loans, savings accounts, credit cards, education loans, trade and forex services, and internet banking. It has expanded its international presence with eight offices located in key global financial centers, including Singapore and Dubai, and a subsidiary in London. These international offices primarily focus on corporate lending, trade finance, syndication, investment banking, and liability businesses. Over the years, Axis Bank has shown consistent growth and stable asset quality, positioning itself as a significant player in the Indian banking sector.
VAST Data
Series E in 2023
VAST Data, Inc. is a technology company that specializes in developing innovative data storage solutions. Headquartered in New York, with additional offices in San Jose, California, the company offers a universal storage platform that utilizes Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. VAST Data's solutions cater to various sectors, including animation and visual effects, deep learning, life sciences, media and broadcasting, and enterprise backup and recovery. The platform is designed to enhance productivity, streamline data management, and accelerate time-to-insight for workload-intensive applications, making it particularly valuable for AI-driven organizations. Founded in 2016, VAST Data has rapidly established itself as a leading player in the data infrastructure market.
CoreWeave
Secondary Market in 2023
CoreWeave operates a cloud infrastructure platform that delivers computing power primarily for blockchain and artificial intelligence/machine learning projects. The company’s specialized GPU cloud system enhances workflows and allows clients to efficiently scale their operations according to the complexity of their models. This flexibility enables users to access tailored compute resources, facilitating innovation and adaptation to rapidly changing computational needs. CoreWeave's platform is designed to support a variety of initiatives, making it a valuable resource for enterprises seeking to optimize their technological capabilities.
Zomato
Post in 2023
Zomato is an online restaurant guide and food delivery platform that enables users to discover, order, and review meals from a wide array of restaurants. With a user base exceeding 55 million across 24 countries, Zomato provides detailed information about dining options, allowing consumers to rate and review restaurants while building personal networks for trusted recommendations. The platform offers various services, including food delivery, table booking, and payment solutions, while also supporting restaurant partners through advertising opportunities and the supply of high-quality ingredients. Zomato operates different segments, with a significant focus on food ordering and delivery in India, alongside its additional services such as Hyperpure and quick commerce.
Iperionx
Post in 2023
IperionX is an American company focused on developing sustainable supply chains for titanium and critical materials. Utilizing patented technologies, it produces high-performance titanium alloys from both titanium minerals and scrap, aiming to reduce energy consumption, costs, and carbon emissions. The company operates a pilot facility in Utah, where it creates titanium metal powders from recycled materials. IperionX also owns the Titan Project, a significant mineral resource in Tennessee that encompasses over 11,000 acres rich in titanium, rare earth elements, silica sand, and zircon. Its products are vital for advanced industries, including aerospace, defense, electric vehicles, and additive manufacturing, where sustainability and low carbon intensity are increasingly important.
SHINE Technologies
Convertible Note in 2023
SHINE Technologies specializes in the development of advanced fusion technology and medical isotopes, catering to various sectors including aerospace, defense, energy, and healthcare. The company utilizes a stepwise approach to deploy its safe and environmentally friendly fusion systems for inspecting industrial components. SHINE's proprietary processes produce critical medical isotopes such as molybdenum-99 and non-carrier-added lutetium-177, which are essential for diagnosing and treating serious health conditions like heart disease and cancer. In addition to its medical isotope production, SHINE aims to address significant energy challenges by scaling its fusion technology to recycle nuclear waste. Through its phased and purpose-driven strategy, SHINE seeks to generate clean and abundant fusion energy, contributing to a safer and healthier world.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
Evozyne
Series B in 2023
Evozyne, LLC is a biotechnology company based in Chicago, Illinois, that specializes in protein design and molecular engineering. Founded in 2020, Evozyne focuses on the discovery and development of therapeutic solutions by harnessing generative AI to create novel proteins with advanced functionality. The company operates multiple business units, including those dedicated to industrial applications, agriculture, energy, biopharmaceuticals, and environmental solutions. Its innovative platform utilizes data-driven models to understand protein folding, function, and the evolvability of synthetic proteins, allowing it to provide customized protein solutions to address complex human and societal challenges.
Generate Biomedicines
Series C in 2023
Generate Biomedicines, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies through its unique platform. The company specializes in Generative Biology, a machine learning-driven approach that analyzes known proteins to understand the relationship between genetic sequences, protein structure, and function. This enables the creation of novel therapeutic proteins, including antibodies, enzymes, and receptors, which are designed to interact specifically and effectively with various therapeutic targets. Founded in 2018 and rebranded from Generate Biologics in 2020, Generate Biomedicines aims to streamline the drug discovery process by generating new biological molecules with significant therapeutic potential.
Rapport Therapeutics
Series B in 2023
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing precision medicines for neurological disorders. The company focuses on creating transformational small-molecule therapies aimed at patients with central nervous system conditions. Leveraging foundational research in neuronal receptor biology, Rapport Therapeutics maps and targets specific neuronal receptor complexes, which are complex assemblies of proteins that include principal receptor subunits and receptor-associated proteins. These receptor-associated proteins are essential for regulating receptor expression and functionality, allowing the company to innovate in the treatment of neurological diseases.
Genesis Therapeutics
Series B in 2023
Genesis Therapeutics Inc. is a biotechnology company focused on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019 and headquartered in South San Francisco, California, the company utilizes a proprietary artificial intelligence platform that integrates deep neural networks, biophysical simulation techniques, and scalable computing infrastructure. This innovative approach enhances the efficiency and accuracy of drug discovery and molecular design, allowing for improved molecular generation and property prediction. By leveraging these advanced technologies, Genesis Therapeutics seeks to transform the drug development process, ultimately aiming to optimize clinical outcomes for patients in need of effective therapies.
GenePlanet
Series B in 2023
GenePlanet is a European biotechnology company that focuses on genetic testing and research. It offers a range of preventive genetic tests aimed at consumers, as well as clinical genetic tests that assist healthcare professionals in therapeutic decision-making. Their tests are based on the latest scientific advancements and adhere to high-quality standards. By utilizing saliva-based DNA testing, GenePlanet provides individuals with personalized insights into their genetic predispositions, allowing them to make informed lifestyle adjustments to mitigate health risks. This approach encourages improved health, vitality, and overall well-being through tailored prevention programs.
Moloco
Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.
Aledade
Series F in 2023
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.
Lightmatter
Series C in 2023
Lightmatter is a technology company that specializes in designing photonic chips that facilitate data processing and communication through light. By leveraging integrated optical technology, Lightmatter develops efficient processors capable of significantly accelerating artificial intelligence-driven computations. Its innovative chips enhance critical operations in neural networks through programmable photonic elements that are fabricated alongside conventional transistors. This approach allows clients to achieve high-quality evaluations while maintaining low power consumption, particularly for software algorithms used in image recognition and natural language processing. Lightmatter serves various sectors, including artificial intelligence, cloud computing, and telecommunications, with the goal of advancing computing tasks through light-based technology.
Saluda Medical
Venture Round in 2023
Saluda Medical is a commercial-stage medical device company focused on developing innovative treatments for chronic neurological conditions, particularly chronic neuropathic pain. The company utilizes a unique closed-loop neuromodulation platform that senses and measures neural responses to stimulation. This technology automatically adjusts the therapy based on real-time neurophysiological feedback, allowing for personalized treatment tailored to each patient's specific needs. By monitoring the patient's neural fingerprint, Saluda Medical’s devices enable the precise delivery of electrical stimulation, ultimately improving the management of chronic back pain and enhancing patient outcomes.
Shoobx
Acquisition in 2023
Financing-Ready at Every Turn. Shoobx is reshaping how private companies get started, raise capital, and exit by raising the bar for cap table management and making venture financing simpler. Everything You Need to Scale and Exit - Fundraise faster than ever before - Have more accurate data and documentation - Automate your legal operations Thousands of users, investors, and attorneys rely on Shoobx to get paperwork right the first time and make legal diligence easy and fast. Automated your next round at shoobx.com.
Asimov
Series B in 2023
Asimov, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on designing and developing genetically engineered therapeutics. Founded in 2017, the company specializes in creating tools for programming living cells, utilizing a multidisciplinary approach that integrates mammalian synthetic biology, computer-aided design, and machine learning. Asimov's platform includes the development of genetic circuits for molecular manufacturing and therapeutic applications, alongside the manufacture of protein biologics, viral vectors, and cell and gene therapies. By combining synthetic biology with biophysical simulations and machine learning algorithms, Asimov aims to optimize the design and production of advanced biologics and gene therapies, thereby contributing to innovations in healthcare.
Apogee Therapeutics
Series B in 2022
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs. Based in San Francisco, California, Apogee Therapeutics was founded in 2022.
Fanatics
Private Equity Round in 2022
Fanatics, Inc. is a leading global e-commerce company specializing in licensed sports merchandise, including fan gear and jerseys. Founded in 1995 and headquartered in Jacksonville, Florida, the company operates a multi-channel retail platform that serves professional sports leagues, media brands, and collegiate teams. Fanatics designs, manufactures, and distributes its products across various channels, including online, mobile, and physical stores, catering to the evolving needs of sports fans in a mobile-first, on-demand culture. The company has additional offices in San Mateo, California, and Manchester, United Kingdom, and aims to enhance the shopping experience by providing a wide range of products that meet the real-time expectations of customers.
FogPharma
Series D in 2022
FogPharma is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, a leader in drug discovery, the company aims to target cancer-causing proteins within cells that are typically inaccessible to traditional drugs. This novel approach allows for the neutralization of these proteins, potentially transforming the treatment landscape for cancer-related diseases. FogPharma collaborates with leading experts in cancer biology and therapy, fostering a network of researchers, investors, and cancer patients dedicated to advancing its mission. The company is committed to delivering this new class of medicines to improve patient outcomes and enhance quality of life for individuals affected by cancer.
Astera Labs
Series D in 2022
Astera Labs, Inc. is a fabless semiconductor company based in Santa Clara, California, specializing in purpose-built connectivity solutions for data-centric systems. Founded in 2017, the company designs and supplies high-speed mixed-signal semiconductor products, including integrated circuits and boards, to enhance PCIe connectivity. Its offerings encompass various systems such as riser cards and GPU booster cards, along with design and testing services. Astera Labs focuses on addressing performance bottlenecks in compute-intensive workloads, catering to applications in server connectivity, distributed machine learning, and high-end gaming graphics. The company collaborates with processor vendors, cloud service providers, and manufacturing partners to deliver critical connectivity performance, flexibility, and observability in its products.
Emalex Biosciences
Series D in 2022
Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.
SiMa.ai
Series B in 2022
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
Local Bounti
Post in 2022
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.
Wasabi
Series D in 2022
Wasabi Technologies, Inc. is a Boston-based company that offers a cloud storage platform tailored for hybrid and multi-cloud media workflows. Founded in 2016, Wasabi provides hot storage solutions that utilize an Amazon S3 compatible API, enabling organizations to store and access data quickly, with average time-to-first-byte speeds under 15 milliseconds. The company's platform is designed to be simple and affordable, allowing customers to access unlimited data without complex pricing tiers or unpredictable egress fees. Wasabi's services cater to various industries, including media and entertainment, education, scientific research, law enforcement, healthcare, and energy. The company has gained recognition for its rapid growth and innovative approach to cloud storage, serving tens of thousands of customers worldwide.
Galvanize Therapeutics
Series B in 2022
Galvanize Therapeutics is a medical technology company specializing in energy-based devices aimed at improving biological processes for therapeutic applications. Founded in 2022 by Apple Tree Partners, the company focuses on developing innovative solutions to treat various medical conditions, including chronic bronchitis, cardiac arrhythmias, and solid tumors. Its platform employs short-duration, high-voltage electrical pulses to create electric fields that destabilize cells through multiple biochemical mechanisms. This technology enhances the ability of medical professionals to provide effective healthcare services, positioning Galvanize Therapeutics as a potential leader in delivering cutting-edge medical innovations.
Study Plus
Series D in 2022
Study Plus is an educational application developed to facilitate collaborative studying.
Aledade
Series E in 2022
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.
SiMa.ai
Series B in 2022
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
Vention
Series C in 2022
Vention Inc. is a digital manufacturing platform that simplifies the design and ordering of custom machines for industrial automation. Founded in 2016 and headquartered in Montreal, Canada, the company offers a cloud-based solution that includes a 3D Machine Builder, which features an extensive library of modular components for applications such as automated equipment, robot cells, tooling, and conveyors. Vention's platform allows engineers and manufacturing professionals to design, program, simulate, and order custom factory equipment efficiently, significantly reducing the time typically required for these processes. Additionally, the integration of artificial intelligence helps streamline the design experience, making industrial automation more accessible to both experienced professionals and newcomers in the field.
X (formerly Twitter)
Post in 2022
X, formerly Twitter, is a global social networking platform that allows its users to send and read 280-character messages. It enables registered users to read and post their tweets through the web, short message service (SMS), and mobile applications. As a global real-time communications platform, X has more than 400 million monthly visitors and 255 million monthly active users around the world. X’s active group of registered members includes World leaders, major athletes, star performers, news organizations, and entertainment outlets. It is currently available in more than 35 languages.
Castle Creek Biosciences
Venture Round in 2022
Castle Creek Biosciences, Inc. is a gene therapy company headquartered in Exton, Pennsylvania, that specializes in developing and commercializing personalized gene therapies for rare skin and connective tissue disorders. Founded in 2015, the company utilizes a fibroblast technology platform that extracts fibroblast cells from a patient's own skin to create localized therapies tailored to the individual’s unique biology. This innovative approach aims to address the underlying causes of diseases that currently have high unmet medical needs, ultimately improving the lives of patients suffering from these underserved conditions.
Starling Bank
Series D in 2022
Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.
BETA Technologies
Series B in 2022
BETA Technologies is an electric aerospace company focused on developing electric aircraft and advanced flight control systems aimed at promoting clean aviation technology. The company designs a self-sufficient ecosystem of electric vertical takeoff and landing (eVTOL) aircraft that meets the transportation needs of people and goods while adhering to environmental principles. BETA's technology encompasses all-electric aircraft and a comprehensive charging infrastructure to support various electric vehicles, enhancing the efficiency and sustainability of transportation. The company also offers training programs for pilots and maintenance personnel, serving clients in cargo, passenger, and emergency response sectors, thereby enabling more efficient, cleaner, and faster transportation solutions.
Dianthus Therapeutics
Series A in 2022
Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for severe autoimmune diseases through targeted therapies. The company's lead candidate, DNTH103, is a monoclonal antibody designed to selectively inhibit a specific component of the immune system, offering potential advantages over existing complement therapies. This treatment aims to improve safety and efficacy for patients suffering from serious autoimmune and inflammatory conditions. Dianthus is committed to advancing its pipeline of next-generation complement therapeutics, supported by a team of experienced professionals in the biotech and pharmaceutical sectors. The company envisions that DNTH103 could be administered as a self-injection for certain patients, enhancing convenience and accessibility in treatment.
Circle
Private Equity Round in 2022
Circle is a financial technology firm that leverages blockchain technology and stablecoins to facilitate payments and e-commerce. Founded in 2013 by Jeremy Allaire and Sean Neville, Circle enhances the way users send and receive money through its platform, Circle Pay. The company offers a cryptocurrency investment product called Circle Invest, enabling users to buy and sell various crypto assets. Additionally, Circle provides over-the-counter trading services through Circle Trade, featuring one of the largest global liquidity pools for digital asset trading, with an average monthly volume of $2 billion. Backed by significant investments from notable firms, Circle operates from its headquarters in Boston and has branches in New York, San Francisco, Dublin, London, and Hong Kong.
Coin Metrics
Series C in 2022
Coin Metrics Inc. is a provider of blockchain and cryptocurrency data analytics, based in Cambridge, Massachusetts. Founded in 2017, the company specializes in delivering market and network data, analytics, and research to various industries and institutions involved in crypto-assets. Its offerings include the CM Network Data Pro, which provides comprehensive historical data on top cryptocurrency assets, and the CM Market Data Feed, which standardizes trade, candle, and order book data from multiple exchanges. Additionally, Coin Metrics offers CM Reference Rates, which present fixed asset pricing in U.S. dollars. By focusing on transparency and actionable data, Coin Metrics aims to empower individuals and organizations to make informed financial decisions related to cryptocurrencies.
Rapyd
Secondary Market in 2022
Rapyd is a payments platform that integrates fintech services into applications, streamlining access to a variety of local payment methods. It empowers e-commerce merchants, gig platforms, challenger wallets, remittance services, online lenders, and traditional banks to overcome the constraints of outdated infrastructure. By facilitating the creation of innovative, mobile-friendly payment solutions, Rapyd enhances the financial capabilities of its users, allowing them to adapt to the evolving demands of the digital economy.
Starry
Post in 2022
Starry, Inc. is an innovative internet company based in Boston, Massachusetts, with an additional operation in New York City. Founded in 2014, the company specializes in developing user-friendly Wi-Fi products and high-speed internet services. Its flagship product, Starry Station, is the first ambient touchscreen Wi-Fi router, designed to provide users with enhanced visibility and control over their home networks. In addition to its hardware, Starry employs advanced technologies to deliver high-speed broadband using hybrid-fiber fixed wireless solutions, offering gigabit-capable internet without the constraints of bundles, data caps, or long-term contracts. The company is committed to prioritizing customer needs, ensuring privacy, and promoting affordable connectivity and digital equity within communities.
LifeMine Therapeutics
Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.
PrognomIQ
Venture Round in 2022
PrognomiQ is a technology company dedicated to advancing early disease detection and treatment, particularly for cancer and other complex diseases. By harnessing multi-omics data, including proteomic, genomic, and metabolomic information, the company aims to enhance understanding and management of health conditions. PrognomiQ's innovative approach allows for the development of advanced medical test products that improve diagnostic capabilities and recurrence monitoring, ultimately seeking to enhance patient outcomes. Through its focus on integrating diverse health data, PrognomiQ is committed to transforming how medical practitioners approach disease detection and treatment.
Menlo Micro
Series C in 2022
Menlo Micro, Inc. specializes in the design and development of electronic switches, particularly through its innovative Ideal Switch technology. This electromechanical switch is capable of handling both AC/DC and RF signals, making it suitable for a range of applications including high-power tunable resonators, filters, broadband power amplifier impedance matching, and electronically steerable antennas. The company's products are utilized in various industries, such as battery management, home automation, electronic vehicles, medical instrumentation, and the industrial Internet of Things, as well as in next generation 5G mobile networks. Founded in 2016 and headquartered in Irvine, California, Menlo Micro aims to enhance the efficiency and performance of advanced systems under high-stress conditions.
Saluda Medical
Private Equity Round in 2022
Saluda Medical is a commercial-stage medical device company focused on developing innovative treatments for chronic neurological conditions, particularly chronic neuropathic pain. The company utilizes a unique closed-loop neuromodulation platform that senses and measures neural responses to stimulation. This technology automatically adjusts the therapy based on real-time neurophysiological feedback, allowing for personalized treatment tailored to each patient's specific needs. By monitoring the patient's neural fingerprint, Saluda Medical’s devices enable the precise delivery of electrical stimulation, ultimately improving the management of chronic back pain and enhancing patient outcomes.
Gousto
Secondary Market in 2022
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by Timo and James, the company addresses the challenges of meal preparation by offering an easy online platform where users can select from a weekly updated menu of recipes. Each recipe is developed by a team of chefs and tested by their friends and families to ensure quality and appeal. Gousto allows subscribers the flexibility to pause their service as needed, making it convenient for those with busy lifestyles. The company has evolved from its initial market stall offerings into a comprehensive service that simplifies the cooking process while promoting healthy eating.
Omada
Series E in 2022
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Somatus
Series E in 2022
Somatus, Inc. is a healthcare company based in McLean, Virginia, specializing in kidney care services. Founded in 2016, it partners with health plans, health systems, nephrology, and primary care groups to offer integrated care for patients with or at risk of developing kidney disease. The company provides a range of services, including home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplantation, and conservative care. Somatus focuses on delaying or preventing the progression of chronic kidney disease and aims to enhance the quality of care through improved coordination and increased utilization of home dialysis and transplantation options. Its approach combines vertically integrated clinical services and technology to optimize patient outcomes.
CelLink
Series D in 2022
CelLink Corporation, founded in 2012 and headquartered in Belmont, California, specializes in the development of flexible conductive backplanes and circuits designed for power electronics. The company focuses on creating high-conductance, large-area flexible circuits that integrate multiple functionalities, including busing, fusing, and voltage and temperature monitoring. These innovations are intended for use in a variety of applications such as batteries, light-emitting diodes, wire harnessing, and solar cells, facilitating efficient power transmission. By offering these advanced circuits, CelLink aims to provide customers with affordable solutions that enhance the performance and reliability of their power-related devices.
Chenjing Tech
Series A in 2022
VR
LeddarTech
Series D in 2022
LeddarTech Inc. is a Canadian company that specializes in developing advanced detection and ranging systems, utilizing time-of-flight measurement technology with infrared LEDs. Its product offerings include smart sensor modules for various applications, such as single-element and multi-element sensor modules, LED-based traffic management sensors, and sensor evaluation kits. These solutions are designed for a wide range of applications, including advanced driver assistance systems (ADAS), autonomous driving, public safety, and industrial monitoring. LeddarTech's flagship platform, LeddarVision™, integrates multiple sensor types to create comprehensive 3D environmental models, facilitating improved perception and navigation capabilities in vehicles. The company aims to address critical sensing challenges for OEMs and automotive suppliers, helping them enhance performance while reducing development time and costs. Founded in 2007 and headquartered in Quebec City, Canada, LeddarTech maintains a research and development office in Toronto and has secured numerous patents in the field of remote sensing technologies.
MNTN
Series D in 2022
MNTN Performance TV is a Connected TV advertising platform that focuses on delivering measurable results for marketers through advanced targeting, measurement, and optimization technologies. The company offers a cloud-based advertising solution that integrates cross-device capabilities across social, mobile, and display advertising. Key features of the platform include audience segmentation, campaign management, a creative ad builder, and comprehensive reporting tools. This enables clients to achieve transparency and maintain control over their campaigns, ultimately driving measurable conversions, revenue, and site visits. MNTN aims to not only meet the immediate goals of TV campaigns but also to create a lasting impact that supports long-term business growth.
Capital Markets Gateway
Series B in 2022
Capital Markets Gateway Inc. is a financial technology firm based in Chicago, Illinois, with additional locations in New York and Seattle. Founded in 2015, the company focuses on modernizing equity capital markets by providing a platform that delivers real-time information and analytics to investors, underwriters, and issuers. This platform enables users to monitor capital raising activities, conduct due diligence, and make informed investment decisions while facilitating collaboration among participants. Since its launch in 2017, Capital Markets Gateway has garnered the trust of over 100 buy-side firms, managing a combined $20 trillion in assets under management, along with support from 10 investment banks. The platform emphasizes transparency and workflow efficiencies, serving as a digital system of record for firm-wide deal activity.
Sonder Holdings
Post in 2022
Sonder Holdings is a hospitality company that leases hotel-style apartments to travelers, offering a variety of accommodation options, including rooms, suites, and apartments. Formerly known as Flatbook Corp., the company rebranded as Sonder Canada Inc. in 2016 and operates under the name Sonder. Incorporated in 2018 and based in Montreal, Canada, Sonder provides both short and long-term stays across more than 30 cities in North America, Europe, and the Middle East. The company focuses on delivering a tech-driven, seamless experience through a user-friendly app that allows guests to access self-service features and 24/7 support. Each Sonder unit is carefully selected, designed, and managed by the company, ensuring a consistent and thoughtfully curated experience for travelers.
Bolt
Series F in 2022
Bolt is the first European app with a mission to make cities for people, not cars. Bolt has 100 million customers in 45 countries across Europe and Africa. The company challenges personal car ownership, offering better alternatives for every use case, including ride-hailing, shared cars and scooters, and food and grocery delivery. Bolt was founded in 2013 and is headquartered in Tallinn, Estonia.
Oddity
Venture Round in 2022
ODDITY is a consumer-tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company owns IL MAKIAGE and SpoiledChild.
SalioGen Therapeutics
Series B in 2022
SalioGen Therapeutics is a biotechnology company focused on developing innovative gene therapies for inherited disorders. Utilizing its proprietary Exact DNA Integration Technology (EDIT) platform, the company employs mammal-derived enzymes known as Saliogase to facilitate genome engineering. This approach allows for non-viral delivery of genes of any size, offering significant advantages in manufacturing and application. SalioGen's technology aims to provide safe, durable, and affordable solutions that could transform treatment options for patients with genetic conditions, while also enhancing the efficiency of cell therapy and biologics manufacturing within the healthcare sector.
DNA Script
Series C in 2022
DNA Script is a pioneering company in the field of DNA synthesis, focused on enhancing life science and human health through innovative technology. The company has developed a unique enzymatic process that allows for the production of synthetic DNA using natural enzymes. This technology underpins their benchtop DNA printer, SYNTAX, which enables laboratories to synthesize their own oligonucleotides. By doing so, DNA Script provides researchers with greater control over their workflows, facilitating faster access to essential genomic materials for various applications in molecular biology and genomics. This capability accelerates experimentation and supports the development of new therapeutics, positioning DNA Script as a key player in the biotechnology sector.
Asoview
Series E in 2021
Asoview is an online booking platform that specializes in facilitating reservations for a diverse range of tourist activities and experiences. The company's services encompass various options, including water and motorsports, sightseeing tours, horse trekking, cooking classes, and cultural activities. By providing a comprehensive and user-friendly interface, Asoview enables customers to easily discover and book activities that match their interests, streamlining the planning process for travelers and enhancing their overall experience.
EQRx
Post in 2021
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.
Cvent
Post in 2021
Cvent is a technology provider focused on enhancing the meetings, events, and hospitality industries through a comprehensive event marketing and management platform. The company offers software solutions that facilitate online event registration, venue selection, event marketing, and management, as well as attendee engagement for various formats, including virtual, hybrid, and onsite events. Cvent's tools are designed to help event planners and marketers optimize the revenue potential of their programs while simplifying the management of each stage in the event lifecycle. By integrating these functionalities, Cvent aims to streamline the planning process and improve overall event effectiveness.
P3 Health Partners
Post in 2021
P3 Health Partners is a patient-centered and physician-led population health management company based in Henderson, Nevada. Founded in 2017, P3 focuses on providing primary health care services through clinical operations, population health management, and consulting. The company is dedicated to enhancing patient outcomes and experiences by leveraging a coordinated network of community providers. By integrating existing healthcare resources, P3 aims to improve care delivery while reducing costs. The organization comprises a team of doctors, clinicians, and support professionals who are committed to delivering value-based care, ensuring greater satisfaction for both patients and healthcare providers.
Local Bounti
Post in 2021
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.
Innovid
Post in 2021
Innovid is an independent omni-channel advertising and analytics platform designed specifically for television. The company offers a comprehensive software solution that enables advertisers to personalize, deliver, and measure innovative advertising experiences across various devices and media outlets. Its services encompass ad serving, measurement, and creative optimization for TV advertisements, catering to advertisers, publishers, and media agencies. With a strong presence in the U.S., Canada, EMEA, APAC, and LATAM, Innovid focuses on enhancing the effectiveness of TV advertising by providing tools that facilitate the creation and analysis of ads in connected TV, mobile TV, and desktop environments.
Quell Therapeutics
Series B in 2021
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions. Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.
GaN Systems
Venture Round in 2021
GaN Systems Inc. is a semiconductor company specializing in the development and manufacture of gallium nitride power switching transistors. Founded in 2008 and headquartered in Ottawa, Canada, the company also has offices in Japan, China, and Germany. It offers a variety of products, including 650 V and 100 V E-HEMT transistors and wireless power amplifiers, which are utilized in various applications such as consumer electronics, industrial systems, renewable energy solutions, and transportation. GaN Systems aims to address significant challenges in power systems by providing high-efficiency and compact power solutions, ultimately enabling improvements in energy efficiency and cost-effectiveness for its clients across different sectors. The company serves a diverse market, including consumer brands and enterprise equipment manufacturers in Asia and beyond.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.